Apotex announced the launch of Mometasone Furoate Monohydrate Nasal Spray, the first generic version of Merck’Nasonex

Nasonex is indicated for the treatment of nasal congestion. It is a corticosteroid demonstrating potent anti-inflammatory properties. The precise mechanism of corticosteroid action on allergic rhinitis is not known but corticosteroids have been shown to have a wide range of effects on multiple cell types (eg, mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (eg, histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation.

Mometasone Furoate Monohydrate Nasal Spray is available in a 50mcg per spray strength.

For more information call (800) 706-5575 or visit Apotex.com.